Valuation Gedeon Richter LUXEMBOURG S.E.

Stocks

CHWGR

US3684672054

Pharmaceuticals

End-of-day quote LUXEMBOURG S.E. Other stock markets 16/06/2026			5-day change	1st Jan Change
39.80 ^USD	-0.50%		+2.58%	+31.79%

16/06	AI in Hungary could unlock productivity gains of EUR15 billion, McKinsey says	RE
10/06	Gedeon Richter Plc. and Hetero Labs Ltd. Announce Global Collaboration Agreement for Joint Development, Registration, and Commercialization of Semaglutide Injection	CI

Company Valuation: Gedeon Richter

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	16,19,625	15,42,290	16,27,029	18,93,161	17,99,226	21,72,240	-	-
Change	-	-4.77%	5.49%	16.36%	-4.96%	20.73%	-	-
Enterprise Value (EV) ¹	15,59,769	13,95,557	15,46,536	17,82,343	15,88,618	18,57,650	17,50,849	16,32,235
Change	-	-10.53%	10.82%	15.25%	-10.87%	16.93%	-5.75%	-6.77%
P/E Ratio	11.6x	9.94x	10.2x	7.96x	7.76x	8.32x	7.63x	6.97x
PBR	1.78x	1.47x	1.44x	1.49x	1.31x	1.44x	1.3x	1.18x
PEG	-	0.9x	3.41x	0.2x	-2.82x	0.7x	0.85x	0.73x
Capitalization / Revenue	2.57x	1.92x	2.02x	2.21x	1.94x	2.28x	2.12x	1.98x
EV / Revenue	2.47x	1.74x	1.92x	2.08x	1.71x	1.95x	1.71x	1.49x
EV / EBITDA	8.86x	7.1x	6.43x	5.74x	4.5x	5.11x	4.49x	3.85x
EV / EBIT	11.5x	9.09x	8.15x	6.82x	5.42x	6.19x	5.36x	4.64x
EV / FCF	-460x	12.3x	17.9x	8.26x	7.56x	8.74x	7.57x	6.49x
FCF Yield	-0.22%	8.12%	5.6%	12.1%	13.2%	11.4%	13.2%	15.4%
Dividend per Share ²	225	390	-	-	-	620.6	664.4	733
Rate of return	2.58%	4.7%	-	-	-	5.21%	5.58%	6.15%
EPS ²	751	835	860	1,307	1,271	1,432	1,561	1,709
Distribution rate	30%	46.7%	-	-	-	43.3%	42.6%	42.9%
Net sales ¹	6,30,595	8,02,755	8,05,158	8,57,545	9,28,962	9,51,724	10,23,546	10,98,192
EBITDA ¹	1,76,123	1,96,480	2,40,625	3,10,678	3,53,314	3,63,366	3,89,794	4,24,113
EBIT ¹	1,35,832	1,53,555	1,89,817	2,61,157	2,92,851	2,99,996	3,26,732	3,51,898
Net income ¹	1,39,626	1,55,581	1,58,850	2,39,244	2,32,335	2,59,474	2,86,154	3,13,070
Net Debt ¹	-59,856	-1,46,733	-80,493	-1,10,818	-2,10,608	-3,14,590	-4,21,390	-5,40,005
Reference price ²	8,725.00	8,300.00	8,750.00	10,400.00	9,865.00	11,910.00	11,910.00	11,910.00
Nbr of stocks (in thousands)	1,85,630	1,85,818	1,85,946	1,82,035	1,82,385	1,82,388	-	-
Announcement Date	02/03/22	28/02/23	29/02/24	07/04/25	27/02/26	-	-	-

¹HUF in Million²HUF

Estimates

P/E Ratio, Detailed evolution

Sector Comparison:

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
SUN PHARMACEUTICAL INDUSTRIES LTD.	37.14x	7.03x	23.97x	0.83%	4.57TCr
OTSUKA HOLDINGS CO., LTD.	17.28x	1.92x	9.13x	1.4%	3.4TCr
CIPLA LIMITED	26.5x	3.25x	16.66x	0.91%	1.17TCr
ZYDUS LIFESCIENCES LIMITED	23.66x	4.13x	15.38x	0.75%	1.15TCr
KRKA, D. D.	19.79x	3.43x	12.41x	3.44%	928.17Cr
ONO PHARMACEUTICAL CO., LTD.	14.9x	1.96x	7.41x	3.6%	661.59Cr
GLENMARK PHARMACEUTICALS LIMITED	32.74x	3.72x	15.82x	0.24%	643.74Cr
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	40.47x	-	-	-	500.51Cr
Average	26.56x	3.63x	14.40x	1.6%	1.63TCr
Weighted average by Cap.	27.35x	4.32x	16.32x	1.3%